Hervolution receives 2.5M EUR in funding through the European Innovation Council Accelerator

15 Oct 2021
By Hervolution

We are beyond proud to announce that Hervolution is one of just 65 European companies to receive funding through the European Innovation Council Accelerator. Being selected among more than 4000 applicants, the funding of €2.5m

Related news

News Press

HERVOLUTION Therapeutics Appoints Biotech Builder J. Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration

19 Dec 2023

By Hervolution

News

Hervolution will be presenting at Biotech Showcase 2020

03 Dec 2019

By Hervolution

News

HERVOLUTION Therapeutics appoints Moderna Co-Founder and MIT Professor Robert S. Langer as Chair of its Scientific Advisory Board

13 Sep 2023

By Hervolution

News

New Research Reveals the Crucial Role of Endogenous Retrovirus Immunity in Tumor Immunity and Vaccine Development

09 Jun 2023

By Hervolution